Fig. 1.
Structures of FDA-approved smallpox drugs. Tecovirimat (1) inhibits viral release by targeting the envelop protein VP37. Brincidofovir (2) is the prodrug of Cidofovir (3) which targets viral DNA polymerase.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.